This finding suggests, in the light of the low expression of CLDN18 expression in CDX2-positive gastric cancers [46], a strong influence of the activation of highly specific intestinal transcription factor CDX2 in the differentiation of neoplastic cells towards an intestinal phenotype. The gene discussed is CLDN18; the disease is gastric cancer.